Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 9, 2014Journal of Clinical OncologyOpen Access

Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

CCCălin CainapIuliu Hațieganu University of Medicine and PharmacySQShukui QinShanxi Agricultural UniversityWHWen‐Tsung HuangChi Mei Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cainap et al. (2014) studied this question.

synapsesocial.com/papers/6a7c96cd1c02bd024a6ee1b4https://doi.org/10.1200/jco.2013.54.3298
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of vascular endothelial growth factor in human hepatocellular carcinoma1998 · 394 citations
  2. 2BAY 43-9006 Inhibition of Oncogenic RET Mutants2006 · 471 citations
  3. 3Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints1998 · 4,854 citations
  4. 4Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential2005 · 108 citations
  5. 5International trends and patterns of primary liver cancer2001 · 348 citations